The Enterprise Value as of November 2024 (TTM) for Biostage, Inc. (BSTG) is 57.66M

According to Biostage, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 57.66M. This represents a change of -3.86% compared to the average of 59.97M of the last 4 quarters.

Biostage, Inc. (BSTG) Historical Enterprise Value (quarterly & annually)

How has BSTG Enterprise Value performed in the past?

The mean historical Enterprise Value of Biostage, Inc. over the last ten years is 16.03M. The current 57.66M Enterprise Value has changed 35.86% with respect to the historical average. Over the past ten years (40 quarters), BSTG's Enterprise Value was at its highest in in the September 2022 quarter at 79.59M. The Enterprise Value was at its lowest in in the March 2016 quarter at -3585334.00.

Biostage, Inc. (BSTG) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Biostage, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Biostage, Inc. (BSTG) Average Enterprise Value

How has BSTG Enterprise Value performed in the past?

The current Enterprise Value of Biostage, Inc. (BSTG) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Biostage, Inc. (BSTG) Enterprise Value vs. Peers

How is BSTG’s Enterprise Value compared to its peers?

Biostage, Inc.’s Enterprise Value is greater than Biotron Limited (16.98M), greater than Bioasis Technologies Inc. (397.14K), less than Covalon Technologies Ltd. (93.17M), greater than Mosaic ImmunoEngineering Inc. (8.29M), greater than Ceapro Inc. (16.01M), less than Cellectis S.A. (115.55M), less than SanBio Company Limited (38.33B), greater than Alterity Therapeutics Limited (16.97M), greater than Amplia Therapeutics Limited (30.70M), greater than Adynxx, Inc. (581.00), less than Sosei Group Corporation (132.10B), greater than Antibe Therapeutics Inc. (4.67M), greater than Awakn Life Sciences Corp. (4.81M), greater than Tryp Therapeutics Inc. (7.59M), greater than America Great Health (12.38M), greater than Resverlogix Corp. (17.90M), greater than Small Pharma Inc. (34.51M),

Build a custom stock screener for Biostage, Inc. (BSTG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biostage, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Biostage, Inc. (BSTG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Biostage, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.